Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

February 21, 2021

Localized EMT reprograms glial progenitors to promote spinal cord repair.

Developmental Cell
Dana Klatt ShawMayssa H Mokalled
February 20, 2021

Astrocyte-induced synapse formation and ischemic stroke.

Journal of Neuroscience Research
Kazuo Yamagata
February 20, 2021

FOXO3 Regulates Sevoflurane-Induced Neural Stem Cell Differentiation in Fetal Rats.

Cellular and Molecular Neurobiology
Xingyue LiPing Zhao
February 19, 2021

Cell proliferation in the central nervous system of an adult semiterrestrial crab.

Cell and Tissue Research
Gabriela HollmannSilvana Allodi
February 18, 2021
Open Access

Exploration of Learning and Memorizing Ability of OSAS rat with Neuroinflammation

Min LuoMei Yin
February 18, 2021

EphA4 Obstructs Spinal Cord Neuron Regeneration by Promoting Excessive Activation of Astrocytes.

Cellular and Molecular Neurobiology
Xiaogang ChenShouguo Wang
February 17, 2021
Open Access

Reactive astrocyte nomenclature, definitions, and future directions.

Nature Neuroscience
Carole EscartinAlexei Verkhratsky
February 17, 2021

Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke.

Neurochemical Research
Zhe ZhangShinghua Ding
February 16, 2021
Open Access

Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments.

Frontiers in Molecular Neuroscience
Valentina SattaOnintza Sagredo
February 16, 2021

Exposure to fine particulate matter (PM2.5) hampers myelin repair in a mouse model of white matter demyelination.

Neurochemistry International
Roberta ParolisiEnrica Boda
February 16, 2021

Impact of depletion of microglia/macrophages on regeneration after spinal cord injury.

Igor JakovčevskiMelitta Schachner
February 14, 2021

Biocompatibility of ferulic/succinic acid-grafted chitosan hydrogels for implantation after brain injury: A preliminary study.

Materials Science & Engineering. C, Materials for Biological Applications
Doddy D Ojeda-HernándezJuan C Mateos-Díaz
February 14, 2021

Blood-Brain Barrier Mechanisms in Stroke and Trauma.

Handbook of Experimental Pharmacology
Wenlu LiJosephine Lok

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved